LYMPHOTRACK
Live / Registered — Registered and renewed (as of 12 Apr 2024)
What this means for you
Registered since 08 Apr 2014. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 08 Apr 2024).
Record
- Serial number
- 85054965
- Registration number
- 4511019
- Mark type
- Stylized text
- Filed
- 04 Jun 2010
- Published for opposition
- 06 Dec 2011
- Registered
- 08 Apr 2014
- Next maintenance due
- 08 Apr 2024
- Attorney of record
- Sarah W. Matthews
Goods and services
- Class 001 — Chemicals: Reagents for scientific and research use, namely, buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; diagnostic reagent kits for scientific and research use comprised of buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; diagnostic reagent kits for scientific and research use comprised of chemical and biological reagents for non-medical purposes; diagnostic reagents for scientific and research use; diagnostic assays for research, clinical or medical laboratory use
- Class 005 — Pharmaceuticals: Assays for the treatment or diagnosis of disease; medical diagnostic reagents, namely, buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; medical diagnostic kits comprised of buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; medical diagnostic reagent kits comprised of chemical and biological reagents for the treatment, monitoring and diagnosis of disease; medical diagnostic reagent kits comprised of medical reagents for clinical or medical use; medical diagnostic assays for the treatment and diagnosis of disease; medical diagnostic assays for research, clinical and medical use
Owner
- INVIVOSCRIBE, INC., SAN DIEGO, CA, US
- Invivoscribe Technologies, Inc., San Diego, CA, US
- Invivoscribe Technologies, Inc., San Diego, CA, US
- Invivoscribe Technologies, Inc., San Diego, CA, US
Prosecution history
- 12 Apr 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 12 Apr 2024 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 12 Apr 2024 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 11 Apr 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 01 Dec 2023 — TEAS SECTION 8 & 9 RECEIVED
- 08 Apr 2023 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 30 Sept 2020 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 30 Sept 2020 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 30 Sept 2020 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 24 Sept 2020 — TEAS SECTION 8 & 15 RECEIVED
- 08 Apr 2019 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 05 Sept 2018 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 28 Mar 2018 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 28 Mar 2018 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 08 Apr 2014 — REGISTERED-PRINCIPAL REGISTER